The group of NAFLD treated patients with respect to the not treated NAFLD patients showed a statistically greater proportion of subjects with normalization of the following parameters at six months: ALT, γGT, insulinemia, HOMA-IR, and vitamin D, with an associated reduction in CAP. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.